Approval · Notice of Compliance 4145 · 1997
ACTISITE: Notice of Compliance 4145
Issued July 8, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4145
- Date
- July 8, 1997
- Company
- Procter & Gamble Inc.Cincinnati, Ohio, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Antibiotic impregnated filament for topical application
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACTISITE | 02231649 | Cancelled Pre Market |
Medicinal ingredients
- TETRACYCLINE HCL 12.7 MG per PIECE